SE9103332L - Metod foer diagnos av blodkoagulationssjukdomar - Google Patents

Metod foer diagnos av blodkoagulationssjukdomar

Info

Publication number
SE9103332L
SE9103332L SE9103332A SE9103332A SE9103332L SE 9103332 L SE9103332 L SE 9103332L SE 9103332 A SE9103332 A SE 9103332A SE 9103332 A SE9103332 A SE 9103332A SE 9103332 L SE9103332 L SE 9103332L
Authority
SE
Sweden
Prior art keywords
diagnosis
blood coagulation
pct
coagulation diseases
date
Prior art date
Application number
SE9103332A
Other languages
English (en)
Other versions
SE9103332D0 (sv
SE470274B (sv
Inventor
Bjoern Dahlbaeck
Original Assignee
Bjoern Dahlbaeck
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20384300&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE9103332(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bjoern Dahlbaeck filed Critical Bjoern Dahlbaeck
Priority to SE9103332A priority Critical patent/SE470274B/sv
Publication of SE9103332D0 publication Critical patent/SE9103332D0/sv
Priority to DK92913443T priority patent/DK0608235T4/da
Priority to EP92913443A priority patent/EP0608235B2/en
Priority to AT92913443T priority patent/ATE132909T1/de
Priority to PCT/SE1992/000310 priority patent/WO1993010261A1/en
Priority to ES92913443T priority patent/ES2081618T5/es
Priority to AU21980/92A priority patent/AU666484C/en
Priority to JP5509186A priority patent/JP2562000B2/ja
Priority to CA002119761A priority patent/CA2119761C/en
Priority to DE0608235T priority patent/DE608235T1/de
Priority to DE69207607T priority patent/DE69207607T3/de
Publication of SE9103332L publication Critical patent/SE9103332L/sv
Publication of SE470274B publication Critical patent/SE470274B/sv
Priority to US08199328 priority patent/US5443960B1/en
Priority to GR950403711T priority patent/GR3018646T3/el
Priority to HK31697A priority patent/HK31697A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96461—Protein C (3.4.21.69)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
SE9103332A 1991-11-13 1991-11-13 Användning av en in vitro-metod för diagnos av blodkoagulationssjukdomar SE470274B (sv)

Priority Applications (14)

Application Number Priority Date Filing Date Title
SE9103332A SE470274B (sv) 1991-11-13 1991-11-13 Användning av en in vitro-metod för diagnos av blodkoagulationssjukdomar
DE0608235T DE608235T1 (de) 1991-11-13 1992-05-13 Vefahren zur diagnose von störungen der blutgerinnung.
DE69207607T DE69207607T3 (de) 1991-11-13 1992-05-13 Verfahren zur diagnose von störungen der blutgerinnung
ES92913443T ES2081618T5 (es) 1991-11-13 1992-05-13 Metodo para diagnosticar anomalias de la coagulacion de la sangre.
CA002119761A CA2119761C (en) 1991-11-13 1992-05-13 Method for the diagnosis of blood coagulation disorders
AT92913443T ATE132909T1 (de) 1991-11-13 1992-05-13 Vefahren zur diagnose von störungen der blutgerinnung
PCT/SE1992/000310 WO1993010261A1 (en) 1991-11-13 1992-05-13 Method for the diagnosis of blood coagulation disorders
DK92913443T DK0608235T4 (da) 1991-11-13 1992-05-13 Fremgangsmåde til diagnose af blodkoagulationssygdomme
AU21980/92A AU666484C (en) 1991-11-13 1992-05-13 Method for the diagnosis of blood coagulation disorders
JP5509186A JP2562000B2 (ja) 1991-11-13 1992-05-13 血液凝固疾患の診断方法
EP92913443A EP0608235B2 (en) 1991-11-13 1992-05-13 Method for the diagnosis of blood coagulation disorders
US08199328 US5443960B1 (en) 1991-11-13 1994-05-27 Method for the diagnosis of blood coagulation disorders
GR950403711T GR3018646T3 (en) 1991-11-13 1996-01-11 Method for the diagnosis of blood coagulation disorders.
HK31697A HK31697A (en) 1991-11-13 1997-03-13 Method for the diagnosis of blood coagulation disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9103332A SE470274B (sv) 1991-11-13 1991-11-13 Användning av en in vitro-metod för diagnos av blodkoagulationssjukdomar

Publications (3)

Publication Number Publication Date
SE9103332D0 SE9103332D0 (sv) 1991-11-13
SE9103332L true SE9103332L (sv) 1993-05-14
SE470274B SE470274B (sv) 1993-12-20

Family

ID=20384300

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9103332A SE470274B (sv) 1991-11-13 1991-11-13 Användning av en in vitro-metod för diagnos av blodkoagulationssjukdomar

Country Status (2)

Country Link
US (1) US5443960B1 (sv)
SE (1) SE470274B (sv)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716795A (en) * 1991-10-04 1998-02-10 Matschiner; John T. Thrombomodulin-based coagulometric assay of the protein C system
AU2870992A (en) * 1991-10-04 1993-05-03 Board Of Regents Of The University Of Nebraska, The A soluble thrombomodulin-based one-stage assay for vitamin k-dependent coagulation-inhibiting proteins
JPH08506181A (ja) 1993-01-29 1996-07-02 ダールベック，ビョルン 新規抗凝固性補助因子活性
DE69502451T2 (de) * 1994-02-14 1998-09-24 Univ Leiden Verfahren zum nachweis eines genetischen defektes, assoziert mit thrombose und/oder mangelhafter anticoagulanz-reaktion auf aktiviertem protein c
AUPM731394A0 (en) * 1994-08-05 1994-09-01 Life Therapeutics Limited Improved activated protein c resistance test
US5705395A (en) * 1994-11-14 1998-01-06 The Scripps Research Institute Method for diagnosis of thrombotic disorders
US6867045B1 (en) * 1994-11-14 2005-03-15 The Scripps Research Institute Method for diagnosis of thrombotic disorders
US20030143759A1 (en) * 1995-10-20 2003-07-31 Bjorn Dahlback Assays for determining anticoagulant cofactor activity
US5766869A (en) * 1995-11-30 1998-06-16 Ahs Hospital Corp. Factor V ratio blood test for susceptibility to thromboembolism
US5839443A (en) * 1996-05-16 1998-11-24 The Trustees Of Columbia University In The City Of New York Method for inhibiting thrombosis in a patient whose blood is subjected to extracorporeal circulation
US6379975B1 (en) 1996-11-27 2002-04-30 T.A.C. Thrombosis And Coagulation Aktiebolag Methods and reagents for determining protein S
CA2288080C (en) * 1997-04-25 2008-01-22 Pentapharm Ag Method for the functional detection of disorders in the protein c system
DE19749197A1 (de) * 1997-11-07 1999-05-12 Dade Behring Marburg Gmbh Verfahren zur Bestimmung des antikoagulatorischen Potentials einer Probe
AU3461999A (en) * 1998-04-01 1999-10-18 Trustees Of Columbia University In The City Of New York, The Method for inhibiting thrombosis in a patient whose blood is subjected to extracorporeal circulation
US20050250688A1 (en) * 1999-04-01 2005-11-10 The Trustees Of Columbia University In The City Of New York Methods for treating an ischemic disorder and improving stroke outcome
CA2437298A1 (en) * 2000-02-23 2001-08-30 Besst-Test Aps Method for correlating blood coagulation activity with markers in body fluids, e.g. urine
US6432658B1 (en) 2000-09-13 2002-08-13 Affinity Biologicals, Inc. Method for measuring antithrombin activity
US6645768B1 (en) * 2000-10-27 2003-11-11 Biomerieux, Inc. Reagent and kit for determining global coagulability and hemostatic potential
US6743596B1 (en) * 2000-10-27 2004-06-01 Biomerieux, Inc. Method of determining global coagulability hemostatic potential
US6855509B2 (en) * 2000-12-19 2005-02-15 Instrumentation Laboratory Company Protein S functional assay and kit therefor
US7226630B2 (en) * 2002-11-26 2007-06-05 Kraft Foods Holdings, Inc. Edible moisture barrier for food and method of use products
US20040197446A1 (en) * 2003-04-01 2004-10-07 Kraft Foods Holdings, Inc. Edible moisture barrier for food products
US20040253347A1 (en) * 2003-06-16 2004-12-16 Kraft Foods Holdings, Inc. Food products having moisture release system for maintaining texture during shelf life
WO2005031303A2 (en) * 2003-09-22 2005-04-07 University Of North Carolina At Chapel Hill Soluble phospholipids for use in clotting factor assays
HUP1300542A2 (hu) * 2013-09-19 2015-03-30 Diagon Kft Eljárás és mérõrendszer véralvadási jellemzõk meghatározására
CN105203777B (zh) * 2015-09-23 2016-05-04 青岛古高生物科技有限公司 一种活化部分凝血活酶时间测定试剂及其制备方法
CN114354559A (zh) * 2022-01-07 2022-04-15 南京鼓楼医院 一种用于监测人体出凝血功能及状态的试剂盒及应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3516579A1 (de) * 1984-11-19 1986-05-22 Boehringer Mannheim Gmbh, 6800 Mannheim Gerinnungstest auf teststreifen
DE3607559A1 (de) * 1986-03-07 1987-09-10 Boehringer Mannheim Gmbh Verfahren zur photometrischen bestimmung der protein c- und/oder protein s-aktivitaet
US5055412A (en) * 1989-03-21 1991-10-08 Proksch Gary J Factor sensitive reagent for testing of blood coagulation containing ellagic acid and divalent metal ions and method of making the same
WO1991001383A1 (en) * 1989-07-14 1991-02-07 Michigan State University Method for diagnosing blood clotting disorders
US5051357A (en) * 1989-07-14 1991-09-24 Board Of Trustees Operating Michigan State University Method and assay using inactivation of factors Va and VIIIa by activated Protein C to diagnose thrombic disease or assay for Protein C and kit therefor
SE464135B (sv) * 1989-07-14 1991-03-11 Kabivitrum Ab Foerfarande foer bestaemning av funktionell aktivitet av fritt protein s eller protein c i ett plasmaprov
US5169786A (en) * 1989-12-19 1992-12-08 Ortho Diagnostic Systems, Inc. Method of determining levels of extrinsic and intrinsic clotting factors and protein c
US5308756A (en) * 1991-11-20 1994-05-03 Baxter Diagnostics Inc. Protein S chromogenic assay

Also Published As

Publication number Publication date
SE9103332D0 (sv) 1991-11-13
SE470274B (sv) 1993-12-20
US5443960B1 (en) 1999-01-12
US5443960A (en) 1995-08-22

Similar Documents

Publication Publication Date Title
SE9103332L (sv) Metod foer diagnos av blodkoagulationssjukdomar
ATE199820T1 (de) Nachweis der atherosklerose bei menschen
DE69822665D1 (de) Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14-dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen
DE68916693T2 (de) Molekular-Diagnose von Alzheimer-Krankheit.
SE8500104D0 (sv) System for fysiologiska tryckregistreringar
HUP9802264A2 (hu) A vér oxigénszintjének mérésére szolgáló rendszer
MX9302021A (es) Composicion y substrato cromogenico para diagnosticar la enfermedad de alzheimer.
FI933291A (fi) Foerfarande foer paovisning av anti-rna-antikroppar
DE69619236D1 (de) Überwachungsverfahren
WO1992019234A3 (en) Method of treating/preventing substance abuse using 1-alkyl-5(substituted oxy)-2-aminotetralins
ES2093277T3 (es) Metodo para la deteccion de daño epitelial gastrico.
ATE25969T1 (de) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
MX9206339A (es) Nueva proteina inhibidora de trombina a partir de chinches de monte
ES2123741T3 (es) Derivados de bencimidazol, su preparacion y uso.
DK0609242T3 (da) Nyt thrombininhibitorisk protein fra blodmider
AU1726495A (en) Pyridinoline crosslinks as markers of periodontal and peri-implant disease activity
KR880009644A (ko) 궤양성 대장질환 치료용 약한 조성물
SU1405842A1 (ru) Способ лечени печеночных заболеваний
RU94014977A (ru) Способ оценки уровня серонина в цельной крови
KR880009017A (ko) 항바이러스 활성을 갖는 이속사졸 유도체 및 이를 함유하는 약제
DE69013139D1 (de) Mittel zur Vorbeugung, Diagnose und Therapie von rheumatischen, autoimmunen, Haut- und Bindegewebekrankheiten von unbekannter Aetiologie und Verfahren zu seiner Herstellung und Verwendung.
DE68914886D1 (de) Mittel zur Behandlung von Raynaud's Krankheit.
FI903637A0 (fi) Diagnostiska analysfoerfarande och deras anvaendning foer bestaemning av kliniska tillstaond.
ATE45224T1 (de) Verfahren zur diagnose von a.i.d.s.
IT8919216A0 (it) Dispositivo per la cura chirurgica dell'astigmatismo.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 9103332-4

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 9103332-4

Format of ref document f/p: F